Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Xiaoshuan Liang"'
Autor:
Qiucheng Wang, Bo Li, Zhao Liu, Haitao Shang, Hui Jing, Hua Shao, Kexin Chen, Xiaoshuan Liang, Wen Cheng
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Automated breast ultrasound (ABUS) is a useful choice in breast disease diagnosis. The axillary lymph node (ALN) status is crucial for predicting the clinical classification and deciding on the treatment of early-stage breast canc
Externí odkaz:
https://doaj.org/article/60cfb1b9557b4d3cb47af6594ed71d77
Autor:
Xue Gong, Tuozhou Dong, Ming Niu, Xiaoshuan Liang, Shanshan Sun, Youxue Zhang, Yue Li, Dalin Li
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 21, Iss , Pp 804-813 (2020)
The importance of long noncoding RNA (lncRNA) in tumorigenesis has been supported by increasing evidence in recent years. However, the mechanism linking lncRNA function with cancer progression remains poorly understood. lncRNA LCPAT1 plays a role in
Externí odkaz:
https://doaj.org/article/3521f55b06be4b699ee4a3bd62871b14
Autor:
Shanshan Sun, Hao Wu, Xiaohong Wu, Zilong You, Yang Jiang, Xiaoshuan Liang, Zhuo Chen, Ye Zhang, Wei Wei, Yongdong Jiang, Yanbo Chen, Yanni Song, Da Pang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Objective: Triple negative breast cancer (TNBC) is known to have aggressive clinical course and a high risk of recurrence. Given the lack of effective targeted therapy options, paclitaxel-based chemotherapy is still the primary option for TNBC patien
Externí odkaz:
https://doaj.org/article/c25a981761a246d89a30d845b8fb55d4
Autor:
Rui Huang, Jiguang Han, Xiaoshuan Liang, Shanshan Sun, Yongdong Jiang, Bingshu Xia, Ming Niu, Dalin Li, Jian Zhang, Shuo Wang, Wei Wei, Qing Liu, Wei Zheng, Guoqiang Zhang, Yanni Song, Da Panga
Publikováno v:
Cellular Physiology and Biochemistry, Vol 43, Iss 6, Pp 2212-2225 (2017)
Background/Aims: Little is known about the potential mechanism of action for androgen receptor (AR) targeting treatment in estrogen receptor (ER)-negative breast cancer. This study aimed to evaluate AR status and its prognosis in four breast cancer s
Externí odkaz:
https://doaj.org/article/6173a4ea24a44365a0564f203d8456b0
Autor:
Xianyu Zhang, Qian Sun, Ming Shan, Ming Niu, Tong Liu, Bingshu Xia, Xiaoshuan Liang, Wei Wei, Shanshan Sun, Youxue Zhang, Xiaolong Sean Liu, Qingbin Song, Yanmei Yang, Yuyan Ma, Yang Liu, Long Yang, Yanlv Ren, Guoqiang Zhang, Da Pang
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53931 (2013)
ARID1A (AT-rich interactive domain 1A) has recently been identified as a tumor suppressor gene. Its mRNA expression is significantly low in many breast cancers; this is often associated with more aggressive phenotypes. However, the underlying molecul
Externí odkaz:
https://doaj.org/article/ccb189c963c444978ae2596d21b21d86
Autor:
Shanshan Sun, Dalin Li, Ming Niu, Xue Gong, Xiaoshuan Liang, Tuozhou Dong, Youxue Zhang, Yue Li
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 21, Iss, Pp 804-813 (2020)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
The importance of long noncoding RNA (lncRNA) in tumorigenesis has been supported by increasing evidence in recent years. However, the mechanism linking lncRNA function with cancer progression remains poorly understood. lncRNA LCPAT1 plays a role in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05e6ee42dcd022b493f9b1361945cc8
http://www.sciencedirect.com/science/article/pii/S2162253120302043
http://www.sciencedirect.com/science/article/pii/S2162253120302043
Publikováno v:
Journal of Cancer
Background: Lung cancer is the most common cause of death from cancer worldwide and recent studies have revealed that microRNAs play critical roles to regulate lung carcinogenesis. microRNA-129-5p (miR-129-5p) has been reported to regulate cell proli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d67139ac304cd0dfa9d41dda24f69be4
https://doi.org/10.7150/jca.35410
https://doi.org/10.7150/jca.35410
Autor:
Ming Shan, Yang Liu, Guoqiang Zhang, Xiaoshuan Liang, Jiguang Han, Shanshan Sun, Ming Niu, Yanni Song
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Breast cancer (BRCA) is one of the most deadly cancers worldwide, with poor survival rates that could be due to its high proliferation. Human all-alpha dCTP pyrophosphatase 1 (DCTPP1) is implicated in numerous diseases, including cancers. However, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1682e41290862f979251ea6af776828
https://doi.org/10.3389/fonc.2021.641931
https://doi.org/10.3389/fonc.2021.641931
Autor:
Wei Wei, Xiaoshuan Liang, Jing Liu, Yuhang Wang, Quanfu Song, Leha A, Shanshan Sun, Xianyu Zhang, Da Pang, Yongdong Jiang
Background: Triple-negative breast cancer (TNBC) is one of the most aggressive breast cancers, and patients with this subtype usually have a poor prognosis. Early analyses identified that fibroblast growth factor receptor 4 (FGFR4) was involved in br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80c3c5e2cd00c1338c0f3f68b6084701
https://doi.org/10.21203/rs.3.rs-16605/v1
https://doi.org/10.21203/rs.3.rs-16605/v1
Autor:
Yanni Song, Wei Wei, Shanshan Sun, Xiaohong Wu, Hao Wu, Yongdong Jiang, Da Pang, Ye Zhang, Zhuo Chen, Yang Jiang, Yanbo Chen, Zilong You, Xiaoshuan Liang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Objective:Triple negative breast cancer (TNBC) is known to have aggressive clinical course and a high risk of recurrence. Given the lack of effective targeted therapy options, paclitaxel-based chemotherapy is still the primary option for TNBC patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded3b4b361a19084b450c6a9c5fcabca
https://pubmed.ncbi.nlm.nih.gov/33747900
https://pubmed.ncbi.nlm.nih.gov/33747900